Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-45. [PMID: 15269313 DOI: 10.1056/nejmoa033025] [Citation(s) in RCA: 3699] [Impact Index Per Article: 176.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]

For:	Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-45. [PMID: 15269313 DOI: 10.1056/nejmoa033025] [Citation(s) in RCA: 3699] [Impact Index Per Article: 176.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]

Number	Cited by Other Article(s)
3701	Holmer AF. Cetuximab in colon cancer. N Engl J Med 2004;351:1575-6; author reply 1575-6. [PMID: 15470223 DOI: 10.1056/nejm200410073511519] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Abstract Collapse Key Words Collapse MESH Headings Antineoplastic Agents/economics Biomedical Research/economics Drug Costs Drug Industry Humans Neoplasms/drug therapy Neoplasms/economics Neoplasms/mortality Value of Life Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse
3702	Cain MJ. Developments in Oncology-2004. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2004. [DOI: 10.1002/jppr2004343236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse
3703	Glasgow SC, Mutch MG. Predictive and Prognostic Genetic Markers in Colorectal Cancer. SEMINARS IN COLON AND RECTAL SURGERY 2004. [DOI: 10.1053/j.scrs.2005.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Abstract Collapse Key Words Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse
3704	Erlichman C, Sargent DJ. New treatment options for colorectal cancer. N Engl J Med 2004;351:391-2. [PMID: 15269321 DOI: 10.1056/nejme048151] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Abstract Collapse Key Words Collapse MESH Headings Antibodies, Monoclonal/administration & dosage Antibodies, Monoclonal/adverse effects Antibodies, Monoclonal, Humanized Antineoplastic Agents/administration & dosage Antineoplastic Agents/adverse effects Antineoplastic Combined Chemotherapy Protocols/therapeutic use Camptothecin/administration & dosage Camptothecin/adverse effects Camptothecin/analogs & derivatives Cetuximab Colorectal Neoplasms/drug therapy ErbB Receptors/antagonists & inhibitors ErbB Receptors/metabolism Exanthema/chemically induced Humans Irinotecan Research Design Topoisomerase I Inhibitors Collapse Grants Collapse Affiliation(s) Collapse Collaborators Collapse